Source link : https://newshealth.biz/health-news/il-6-drug-promising-in-depression-u-s-more-anxious-ai-risks-in-addiction-medicine/
A single infusion of the interleukin (IL)-6 inhibitor tocilizumab (Actemra) showed greater improvements in depression severity, somatic symptoms, fatigue, and anxiety in patients with difficult-to-treat depression and low-grade inflammation compared with placebo in a proof-of-concept trial. (JAMA Psychiatry) A 3-minute video game-like task was able to monitor depression severity. (PNAS) Nearly half (48%) of Americans […]
The post IL-6 Drug Promising in Depression; U.S. More Anxious; AI Risks in Addiction Medicine first appeared on News Health.
—-
Author : News Health
Publish date : 2026-05-20 18:33:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8